CVS Health (CVS) is down 25% year-to-date and down 34% from its 52-week high. Brian Tanquilut discusses health care stocks and the outlook for pharmacy stocks. He talks about how Jefferies has a buy rating and a $110 price target on CVS. He goes over how CVS had to do two diluted acquisitions which impacted their stock. He also notes that CVS will see earnings pressure in the near-term. Tune in to find out more about the stock market today.